SMS Pharmaceuticals’ legal disputes with Natco Pharma have been amicably settled. Out of the settlement, the Company has received a sum of Rs 15.07 crores from Natco Pharma apart from the balance principal amount receivable from the respective courts.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. The company is diversifying into CRAMS by creating research and manufacturing facilities bettering the requirements of the regulatory markets to appeal to international clientele.